Does RISANKIZUMAB Cause Injection site swelling? 5 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Injection site swelling have been filed in association with RISANKIZUMAB (Skyrizi). This represents 0.2% of all adverse event reports for RISANKIZUMAB.
5
Reports of Injection site swelling with RISANKIZUMAB
0.2%
of all RISANKIZUMAB reports
0
Deaths
0
Hospitalizations
How Dangerous Is Injection site swelling From RISANKIZUMAB?
Of the 5 reports.
Is Injection site swelling Listed in the Official Label?
Yes, Injection site swelling is listed as a known adverse reaction in the official FDA drug label for RISANKIZUMAB.
What Other Side Effects Does RISANKIZUMAB Cause?
Product storage error (396)
Drug ineffective (206)
Psoriasis (138)
Crohn's disease (103)
Arthralgia (100)
Off label use (100)
Product temperature excursion issue (88)
Diarrhoea (72)
Fatigue (70)
Rash (64)
What Other Drugs Cause Injection site swelling?
ETANERCEPT (9,992)
DUPILUMAB (9,582)
ADALIMUMAB (4,428)
EVOLOCUMAB (1,933)
GLATIRAMER (1,836)
IXEKIZUMAB (1,615)
TIRZEPATIDE (1,131)
ENBREL (1,121)
HYDROXYPROGESTERONE CAPROATE (924)
HUMIRA (838)
Which RISANKIZUMAB Alternatives Have Lower Injection site swelling Risk?
RISANKIZUMAB vs RISANKIZUMAB-RZAA
RISANKIZUMAB vs RISDIPLAM
RISANKIZUMAB vs RISEDRONATE
RISANKIZUMAB vs RISEDRONIC ACID
RISANKIZUMAB vs RISPERDAL